Ganciclovir 0.15 % Ophthalmic Gel
RxNorm 388052
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 388052 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ganciclovir 0.15 % Ophthalmic Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ganciclovir 0.0015 mg/MG Ophthalmic Gel
(Atom ID: 12328526)
PSNPrescribable
Prescribable Name (PSN):
Ganciclovir 0.15 % Ophthalmic Gel
(Atom ID: 6386046)
SYPrescribable
Synonym (SY):
Ganciclovir 0.15 % Ophthalmic Gel
(Atom ID: 3027350)
PTPrescribable
Designated preferred name (PT):
Ganciclovir 1.5 mg/g eye gel
(Atom ID: 10299107)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ganciclovir 1.5 mg/1 gram conventional release eye gel (clinical drug)
(Atom ID: 10312951)
Patient Education
Ganciclovir Ophthalmic
Ganciclovir ophthalmic is used to treat herpetic keratitis (dendritic ulcers; eye ulcers caused by a herpes simplex virus infection). Ganciclovir is in a class of medications called antivirals. It works by stopping the spread of the herpes virus in the eye.
[Learn More]
* Please review the disclaimer below.